|
JPS6023120B2
(ja)
|
1979-08-13 |
1985-06-05 |
キッコーマン株式会社 |
アデノシン−３′，５′−環状リン酸アルキルトリエステルの製造法
|
|
DE3027279A1
(de)
|
1980-07-18 |
1982-05-06 |
Byk Gulden Lomberg Chemische Fabrik Gmbh, 7750 Konstanz |
Substituierte adenosin-3',5'-phosphorsaeurebenzyltriester, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
|
|
US4526988A
(en)
|
1983-03-10 |
1985-07-02 |
Eli Lilly And Company |
Difluoro antivirals and intermediate therefor
|
|
JPS61204193A
(ja)
|
1985-03-05 |
1986-09-10 |
Takeda Chem Ind Ltd |
シトシンヌクレオシド類の製造法
|
|
CA1327358C
(en)
|
1987-11-17 |
1994-03-01 |
Morio Fujiu |
Fluoro cytidine derivatives
|
|
JPH0692987A
(ja)
|
1992-09-17 |
1994-04-05 |
Tanabe Seiyaku Co Ltd |
ウリジン誘導体およびその製法
|
|
AU671491B2
(en)
|
1992-12-18 |
1996-08-29 |
F. Hoffmann-La Roche Ag |
N-oxycarbonyl substituted 5'-deoxy-5-fluorcytidines
|
|
US5834436A
(en)
|
1993-04-09 |
1998-11-10 |
The Regents Of The University Of California |
Membrane-permeant second messengers
|
|
US5866548A
(en)
|
1993-04-09 |
1999-02-02 |
The Regents Of The University Of California |
Caged membrane-permeant inositol phosphates
|
|
US5693521A
(en)
|
1993-04-09 |
1997-12-02 |
The Regents Of The University Of California |
Membrane-permeant second messengers
|
|
US5476932A
(en)
|
1994-08-26 |
1995-12-19 |
Hoffmann-La Roche Inc. |
Process for producing N4-acyl-5'-deoxy-5-fluorocytidine derivatives
|
|
US6312662B1
(en)
|
1998-03-06 |
2001-11-06 |
Metabasis Therapeutics, Inc. |
Prodrugs phosphorus-containing compounds
|
|
US20020119443A1
(en)
|
2000-07-21 |
2002-08-29 |
Gilead Sciences, Inc. |
Prodrugs of phosphonate nucleotide analogues and methods for selecting and making same
|
|
DK1320531T3
(da)
|
2000-08-10 |
2011-01-03 |
Pfizer Italia Srl |
Bicyclo-pyrazoler, der er aktive som kinase inhibitorer, fremgangsmåde til fremstilling deraf og farmaceutiske sammensætninger, der indeholder disse
|
|
WO2002092006A2
(en)
|
2001-05-16 |
2002-11-21 |
Micrologix Biotech, Inc. |
Nucleic acid-based compounds and methods of use thereof
|
|
CN1678326A
(zh)
|
2002-06-28 |
2005-10-05 |
埃迪尼克斯(开曼)有限公司 |
用于治疗黄病毒感染的2'－c－甲基－3'－o－l－缬氨酸酯核糖呋喃基胞苷
|
|
WO2005018330A1
(en)
|
2003-08-18 |
2005-03-03 |
Pharmasset, Inc. |
Dosing regimen for flaviviridae therapy
|
|
CA2589850C
(en)
|
2004-12-17 |
2012-05-01 |
Eli Lilly And Company |
Amide prodrug of gemcitabine, compositions and use thereof
|
|
WO2007027248A2
(en)
|
2005-05-16 |
2007-03-08 |
Valeant Research & Development |
3', 5' - cyclic nucleoside analogues for treatment of hcv
|
|
WO2007022073A2
(en)
|
2005-08-12 |
2007-02-22 |
Merck & Co., Inc. |
Novel 2'-c-methyl and 4'-c-methyl nucleoside derivatives
|
|
ES2436404T3
(es)
|
2005-10-03 |
2013-12-30 |
University Health Network |
Inhibidores ODCasa para el tratamiento de malaria
|
|
US20090069557A1
(en)
|
2006-02-06 |
2009-03-12 |
Dr. Reddy's Laboratories Ltd. |
Preparation of gemcitabine
|
|
WO2007094135A1
(ja)
*
|
2006-02-15 |
2007-08-23 |
Gifu University |
オリゴヌクレオチド誘導体及びその利用
|
|
FR2907786B1
(fr)
|
2006-10-27 |
2009-09-18 |
Univ Grenoble 1 |
Thionucleosides et applications pharmaceutiques
|
|
US20080008682A1
(en)
|
2006-07-07 |
2008-01-10 |
Chong Lee S |
Modulators of toll-like receptor 7
|
|
KR20090057050A
(ko)
|
2006-09-01 |
2009-06-03 |
유니버시티 오브 조지아 리서치 파운데이션, 인코포레이티드 |
암치료를 위한 트록사시타빈 전구약물
|
|
WO2008083465A1
(en)
|
2007-01-08 |
2008-07-17 |
University Health Network |
Pyrimidine derivatives as anticancer agents
|
|
CN101657462B
(zh)
|
2007-05-25 |
2013-06-05 |
上海特化医药科技有限公司 |
卡培他滨的制备方法及其中间体
|
|
WO2009042064A2
(en)
|
2007-09-21 |
2009-04-02 |
Nektar Therapeutics Al, Corporation |
Oligomer-nucleoside phosphate conjugates
|
|
JP2011503084A
(ja)
|
2007-11-07 |
2011-01-27 |
シェーリング コーポレイション |
新規の細胞周期チェックポイント調節剤およびこれらの調節剤とチェックポイント阻害剤との併用
|
|
KR101013312B1
(ko)
|
2007-11-19 |
2011-02-09 |
한미홀딩스 주식회사 |
카페시타빈의 제조방법 및 이에 사용되는 β-아노머가강화된 트리알킬카보네이트 화합물의 제조방법
|
|
WO2009082846A1
(fr)
|
2007-12-28 |
2009-07-09 |
Topharman Shanghai Co., Ltd. |
Dérivé hydroxyle de la capécitabine, ses procédés de préparation et ses utilisations pour préparer la capécitabine
|
|
EP2096114A1
(en)
|
2008-02-27 |
2009-09-02 |
Bayer CropScience AG |
Insecticidal Derivates of Substituted Phosphorylated Phenylalkyl Iminooxazolines and Iminothiazolines
|
|
US8173621B2
(en)
|
2008-06-11 |
2012-05-08 |
Gilead Pharmasset Llc |
Nucleoside cyclicphosphates
|
|
KR20110059743A
(ko)
|
2008-09-03 |
2011-06-03 |
난양 테크놀러지컬 유니버시티 |
펩티드 핵산 단량체 및 올리고머
|
|
US20110305769A1
(en)
|
2008-11-17 |
2011-12-15 |
Enzon Pharmaceuticals, Inc. |
Branched cationic lipids for nucleic acids delivery system
|
|
US8603999B2
(en)
|
2008-12-05 |
2013-12-10 |
Commonwealth Scientific And Industrial Research Organisation |
Amphiphile prodrugs
|
|
PA8855601A1
(es)
|
2008-12-23 |
2010-07-27 |
|
Forformidatos de nucleósidos
|
|
CN101525361B
(zh)
|
2009-04-21 |
2010-11-17 |
济南圣鲁金药物技术开发有限公司 |
基于吉西他滨结构的前药及其合成方法及应用
|
|
CN101875680B
(zh)
|
2009-04-28 |
2012-07-25 |
上海信旗医药科技有限公司 |
一种核苷类化合物及其制备方法和应用
|
|
JO3027B1
(ar)
|
2009-05-14 |
2016-09-05 |
Janssen Products Lp |
نيوكليوسيدات يوراسيل سبيرواوكسيتان
|
|
CN101921303A
(zh)
|
2009-06-09 |
2010-12-22 |
曾慧慧 |
苯并异硒唑酮二氟胞苷类化合物及其制备方法和其用途
|
|
US8455451B2
(en)
|
2009-09-21 |
2013-06-04 |
Gilead Sciences, Inc. |
2'-fluoro substituted carba-nucleoside analogs for antiviral treatment
|
|
EP2558466A4
(en)
|
2010-04-14 |
2013-11-13 |
Univ California |
PHOSPHONATES WITH REDUCED TOXICITY FOR THE TREATMENT OF VIRUS INFECTIONS
|
|
CN102351931B
(zh)
|
2010-09-07 |
2014-01-22 |
河南省科学院高新技术研究中心 |
嘧啶核苷衍生物、合成方法及其在制备抗肿瘤、抗病毒药物中的应用
|
|
WO2012040126A1
(en)
|
2010-09-22 |
2012-03-29 |
Alios Biopharma, Inc. |
Substituted nucleotide analogs
|
|
WO2012078416A2
(en)
|
2010-12-06 |
2012-06-14 |
Rfs Pharma, Llc |
Monophosphate prodrugs of dapd and analogs thereof
|
|
CA2819041A1
(en)
|
2010-12-22 |
2012-06-28 |
Alios Biopharma, Inc. |
Cyclic nucleotide analogs
|
|
CN102219817A
(zh)
|
2011-04-12 |
2011-10-19 |
连云港杰瑞药业有限公司 |
活性偶联剂用于氟化嘧啶化合物烷氧羰酰化的方法
|
|
GEP201706721B
(en)
|
2012-03-21 |
2017-08-25 |
Alios Biopharma Inc |
Substituted nucleosides, nucleotides and analogs thereof
|
|
US9296778B2
(en)
*
|
2012-05-22 |
2016-03-29 |
Idenix Pharmaceuticals, Inc. |
3′,5′-cyclic phosphate prodrugs for HCV infection
|
|
MX2014014323A
(es)
|
2012-05-25 |
2015-02-12 |
Janssen R & D Ireland |
Nucleosidos de espirooxetano de uracilo.
|
|
CN103665043B
(zh)
|
2012-08-30 |
2017-11-10 |
江苏豪森药业集团有限公司 |
一种替诺福韦前药及其在医药上的应用
|
|
WO2014043380A1
(en)
*
|
2012-09-14 |
2014-03-20 |
Ligand Pharmaceuticals Incorporated |
Novel nucleotide prodrug compounds and use
|
|
WO2014047199A1
(en)
|
2012-09-19 |
2014-03-27 |
The Research Foundation For The State University Of New York |
Novel prodrugs for selective anticancer therapy
|
|
EP2906579B1
(en)
|
2012-10-08 |
2018-04-18 |
Idenix Pharmaceuticals LLC. |
2'-chloro nucleoside analogs for hcv infection
|
|
EP2909209B1
(en)
|
2012-10-17 |
2022-08-03 |
Merck Sharp & Dohme LLC |
2'-cyano substituted nucleoside derivatives and methods of use thereof for treatment of viral diseases
|
|
EP2912047B1
(en)
|
2012-10-29 |
2016-08-24 |
Cipla Limited |
Antiviral phosphonate analogues and process for preparation thereof
|
|
CN104955458A
(zh)
|
2012-11-07 |
2015-09-30 |
Z·索 |
取代的吉西他滨芳基酰胺类似物和使用所述类似物的治疗方法
|
|
JP2016501200A
(ja)
|
2012-11-19 |
2016-01-18 |
メルク・シャープ・アンド・ドーム・コーポレーションＭｅｒｃｋ Ｓｈａｒｐ ＆ Ｄｏｈｍｅ Ｃｏｒｐ． |
ウイルス性疾患を処置するための２−アルキニル置換ヌクレオシド誘導体
|
|
BR112015014457A2
(pt)
|
2012-12-21 |
2017-11-21 |
Alios Biopharma Inc |
composto ou sal farmaceuticamente aceitável do mesmo e composição farmacêutica e respectivos usos e processos para melhorar ou tratar infecção de hcv, para inibir a atividade da ns5b polimerase do vírus da hepatite c e a replicação de vírus da hepatite c
|
|
WO2014124430A1
(en)
|
2013-02-11 |
2014-08-14 |
Emory University |
Nucleotide and nucleoside therapeutic compositions and uses related thereto
|
|
WO2014145207A1
(en)
|
2013-03-15 |
2014-09-18 |
Ohio State Innovation Foundation |
Substituted gemcitabine bicyclic amide analogs and treatment methods using same
|
|
US9765107B2
(en)
|
2013-06-18 |
2017-09-19 |
Merck Sharp & Dohme Corp. |
Cyclic phosphonate substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases
|
|
EP3074399A1
(en)
|
2013-11-27 |
2016-10-05 |
Idenix Pharmaceuticals LLC |
2'-dichloro and 2'-fluoro-2'-chloro nucleoside analogues for hcv infection
|
|
CN105934438A
(zh)
|
2013-11-27 |
2016-09-07 |
艾登尼克斯药业有限公司 |
用于治疗肝癌的核苷酸
|
|
CN106459130A
(zh)
|
2014-03-03 |
2017-02-22 |
纽科利制药公司 |
吉西他滨类似物
|
|
US10202411B2
(en)
|
2014-04-16 |
2019-02-12 |
Idenix Pharmaceuticals Llc |
3′-substituted methyl or alkynyl nucleosides nucleotides for the treatment of HCV
|
|
KR20170005492A
(ko)
|
2014-05-28 |
2017-01-13 |
아이데닉스 파마슈티칼스 엘엘씨 |
암의 치료를 위한 뉴클레오시드 유도체
|
|
CN107295800A
(zh)
*
|
2015-02-25 |
2017-10-24 |
配体药物公司 |
吉西他滨衍生物
|
|
WO2017019581A1
(en)
|
2015-07-29 |
2017-02-02 |
Merck Sharp & Dohme Corp. |
Process for making phosphorus-containing nucleoside prodrug compounds
|
|
JP6743135B2
(ja)
|
2015-09-02 |
2020-08-19 |
アッヴィ・インコーポレイテッド |
抗ウィルス性テトラヒドロフラン誘導体
|
|
CN106554382B
(zh)
|
2015-09-29 |
2019-12-03 |
四川科伦博泰生物医药股份有限公司 |
核苷磷酰胺类化合物及其制备方法和药物中的应用
|
|
EP3471738A4
(en)
|
2016-06-20 |
2020-01-01 |
Merck Sharp & Dohme Corp. |
CYCLIC PHOSPHONATE-SUBSTITUTED NUCLEOSIDE DERIVATIVES AND METHOD FOR USE THEREOF FOR TREATING VIRUS DISEASES
|
|
EP3471737B1
(en)
|
2016-06-20 |
2025-06-04 |
Merck Sharp & Dohme LLC |
Cyclic phosphate substituted nucleoside compounds and methods of use thereof for the treatment of viral diseases
|
|
KR20190057277A
(ko)
|
2016-06-24 |
2019-05-28 |
에모리 유니버시티 |
B형 간염 바이러스 치료용 포스포아미데이트
|
|
CN106317116A
(zh)
|
2016-08-19 |
2017-01-11 |
张红利 |
磷酰胺核苷类化合物及其药学上可接受的盐与应用、药物组合物
|
|
US20190365788A1
(en)
|
2016-11-21 |
2019-12-05 |
Idenix Pharmaceuticals Llc |
Cyclic phosphate substituted nucleoside derivatives for the treatment of liver diseases
|
|
CN109863160B
(zh)
|
2016-12-23 |
2022-06-07 |
四川科伦博泰生物医药股份有限公司 |
核苷磷酸类化合物及其制备方法和用途
|
|
US10688112B2
(en)
*
|
2017-07-13 |
2020-06-23 |
Emory University |
Lipid disulfide prodrugs and uses related thereto
|
|
EP3661513A4
(en)
|
2017-07-31 |
2021-07-14 |
January Therapeutics, Inc. |
ORGANOPHOSPHATE DERIVATIVES
|
|
US10435429B2
(en)
|
2017-10-03 |
2019-10-08 |
Nucorion Pharmaceuticals, Inc. |
5-fluorouridine monophosphate cyclic triester compounds
|
|
CN109956986B
(zh)
|
2017-12-22 |
2021-04-27 |
浙江柏拉阿图医药科技有限公司 |
肝递送吉西他滨前体药物核苷环磷酸酯化合物及应用
|
|
KR102708995B1
(ko)
|
2018-01-10 |
2024-09-23 |
누코리온 파마슈티컬스, 인코포레이티드. |
포스포르(포스포론)아미다타세탈 및 포스프(온)아탈세탈 화합물
|
|
CN111801339B
(zh)
*
|
2018-01-19 |
2025-06-24 |
纽科利制药公司 |
5-氟尿嘧啶化合物
|
|
US11427550B2
(en)
*
|
2018-01-19 |
2022-08-30 |
Nucorion Pharmaceuticals, Inc. |
5-fluorouracil compounds
|
|
US20210038628A1
(en)
|
2018-03-02 |
2021-02-11 |
January Therapeutics, Inc. |
Nanoparticle compositions
|
|
WO2020154917A1
(en)
|
2019-01-29 |
2020-08-06 |
Minghui Pharmaceutical (Shanghai) Limited |
Phosphate and phosphonate based compounds of 6-thio-2'-deoxyguanosine as anti-cancer agents
|
|
MX2021012894A
(es)
|
2019-04-22 |
2021-11-17 |
Ligand Pharm Inc |
Compuestos ciclicos de fosfato.
|
|
CN113906040B
(zh)
|
2019-05-03 |
2024-06-14 |
拓臻制药公司 |
用于治疗癌症的化合物
|
|
MX2022000573A
(es)
|
2019-07-17 |
2022-02-10 |
Nucorion Pharmaceuticals Inc |
Compuestos ciclicos de desoxirribonucleotido.
|
|
JP2023523415A
(ja)
*
|
2020-04-21 |
2023-06-05 |
リガンド・ファーマシューティカルズ・インコーポレイテッド |
ヌクレオチドプロドラッグ化合物
|
|
WO2022086858A1
(en)
|
2020-10-19 |
2022-04-28 |
Aptinyx Inc. |
Methods of treating post-traumatic stress disorder and related conditions
|
|
EP4232456A4
(en)
|
2020-10-21 |
2026-04-01 |
Ligand Pharm Inc |
COMPOUNDS OF ANTIVIRAL MEDICINES
|
|
WO2022245584A1
(en)
|
2021-05-17 |
2022-11-24 |
Ligand Pharmaceuticals Incorporated |
Unnatural configuration nucleotide prodrug compounds
|